Viewing StudyNCT00558545



Ignite Creation Date: 2024-05-05 @ 6:49 PM
Last Modification Date: 2024-10-26 @ 9:37 AM
Study NCT ID: NCT00558545
Status: TERMINATED
Last Update Posted: 2009-12-02
First Post: 2007-11-13

Brief Title: A Phase 1-2 XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer
Sponsor: Aegera Therapeutics
Organization: Aegera Therapeutics

Conditions & Keywords Data

Conditions:
Name
Human Mammary Carcinoma
Keywords:
Name View
oligonucleotide View
Breast View
paclitaxel View
antisense View